King & Wood Mallesons (KWM) has advised Hong Kong stock exchange listed Suzhou Basecare Medical Corporation Limited (Suzhou Basecare Medical) on its acquisition of BMX Holdco (Biomedx), a Singapore based business specialising in IVF incubator and culture media.
The deal assists in forming a closed-loop industrial chain of independent innovative products in the field of assisted reproduction. It also provides extensive potential to grow Suzhou Basecare Medical’s strong commercial network and customer base in China through Biomedx’s global network.
The KWM team advising on the deal stretches across the Asia Pacific region. The team was led by Partners Nicholas Molan and Anthony Boogert, and supported by Solicitor, Mary Li, Partner, Scott Bouvier and Senior Associate, Melissa Miller.
Commenting on the deal, Partner Nicholas Molan said:
“Healthcare has and continues to be a significant focus for KWM, particularly amid a challenging market, underlying demand for healthcare and the growing Asian middle class make it a natural fit for a firm with Asian DNA like ours”.
Further commenting on the deal, Partner Anthony Boogert said:
“Congratulations to Suzhou Basecare Medical on this significant transaction. Having advised on numerous transactions in the IVF sector, we are confident this deal will be extremely successful for Suzhou Basecare Medical and its customers.
The deal also signals the significant demand and continued growth opportunities for the healthcare industry in the region.”
